Cargando…
miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells
Arsenic trioxide (ATO) resistance is a challenging problem in chemotherapy. However, the underlying mechanisms remain to be elucidated. In this study, we identified a high level of expression of miR-155 in a human lung adenocarcinoma A549R cell line that is highly resistant to ATO. We showed that th...
Autores principales: | Gu, Shiyan, Lai, Yanhao, Chen, Hongyu, Liu, Yuan, Zhang, Zunzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610328/ https://www.ncbi.nlm.nih.gov/pubmed/28939896 http://dx.doi.org/10.1038/s41598-017-06061-x |
Ejemplares similares
-
Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer
por: Ji, Hui, et al.
Publicado: (2014) -
hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013) -
Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis
por: ZHENG, SHU-RONG, et al.
Publicado: (2012) -
miR-155 Inhibits Mouse Osteoblast Differentiation by Suppressing SMAD5 Expression
por: Gu, Yue, et al.
Publicado: (2017) -
miR-155 in the Resolution of Atherosclerosis
por: Bruen, Robyn, et al.
Publicado: (2019)